Mannitol Side Effects
Recent Questions and Answers about Mannitol
How do I determine oxygen requirements for a bacteria?
View Community-reported Mannitol side effects
Add Your Side Effect to the Community Database
Help Community - Describe Your Mannitol Side Effect
Have You dealt with a Mannitol side effect? Share your experience
Mannitol Side Effects summary
Total Mannitol reports: 14.Mannitol FDA safety alerts: No.
.
Take Mannitol Side Effects Survey, Discuss Mannitol with others
Mannitol Side Effects: maculopathy, visual disturbance, macular oedema, central nervous system lymphoma, blood brain barrier defect, visual acuity reduced, tumour lysis syndrome, thrombocytopenia, malignant neoplasm progression, disease progression,
Mannitol Usage.
If you have questions about Mannitol, you can ask a Health Expert or Ask Patient Community about Mannitol.
Mannitol Side Effects reported to FDA
Mannitol Side Effects Report #5404974-1
Consumer or non-health professional from UNITED STATES reported MANNITOL problem on July 22, 2007. Female patient, 54 years of age, was diagnosed with nervous system disorder, central nervous system lymphoma and was treated with MANNITOL. After drug was administered, patient experienced the following problems/side effects: maculopathy. MANNITOL dosage: unknown. During the same period patient was treated with METHOTREXATE ECTION, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE. Patient recovered.
Mannitol Side Effects Report #5404976-5
MANNITOL problem was reported by a Consumer or non-health professional from UNITED STATES on July 22, 2007. Female patient, 57 years of age, was diagnosed with brain operation, central nervous system lymphoma and was treated with MANNITOL. After drug was administered, patient experienced the following problems/side effects: maculopathy. MANNITOL dosage: unknown. During the same period patient was treated with METHOTREXATE ECTION, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE. Patient recovered.
Mannitol Side Effects Report #5404977-7
Health Professional from UNITED STATES reported MANNITOL problem on July 22, 2007. Female patient, 65 years of age, was diagnosed with nervous system disorder, central nervous system lymphoma and was treated with MANNITOL. After drug was administered, patient experienced the following problems/side effects: maculopathy. MANNITOL dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE. Patient recovered.
Mannitol Side Effects Report #5404978-9
MANNITOL problem was reported by a Health Professional from UNITED STATES on July 22, 2007. Female patient, 66 years of age, was diagnosed with blood brain barrier defect, central nervous system lymphoma and was treated with MANNITOL. After drug was administered, patient experienced the following problems/side effects: macular oedema, maculopathy, visual disturbance. MANNITOL dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE. Patient recovered.
Mannitol Side Effects Report #5404982-0
Health Professional from UNITED STATES reported MANNITOL problem on July 22, 2007. Female patient, 66 years of age, was diagnosed with nervous system disorder, central nervous system lymphoma and was treated with MANNITOL. After drug was administered, patient experienced the following problems/side effects: macular oedema, maculopathy, visual acuity reduced. MANNITOL dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE. Patient recovered.
Mannitol Side Effects Report #5404984-4
MANNITOL problem was reported by a Health Professional from UNITED STATES on July 22, 2007. Female patient, 73 years of age, was diagnosed with brain operation, central nervous system lymphoma and was treated with MANNITOL. After drug was administered, patient experienced the following problems/side effects: maculopathy. MANNITOL dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE. Patient recovered.
Mannitol Side Effects Report #5404985-6
Health Professional from UNITED STATES reported MANNITOL problem on July 22, 2007. Female patient, 34 years of age, was diagnosed with nervous system disorder, central nervous system lymphoma and was treated with MANNITOL. After drug was administered, patient experienced the following problems/side effects: maculopathy. MANNITOL dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE. Patient recovered.
Mannitol Side Effects Report #5414742-2
MANNITOL problem was reported by a Physician from UNITED STATES on Aug 03, 2007. Female patient, 73 years of age, was diagnosed with blood brain barrier defect, central nervous system lymphoma and was treated with MANNITOL. After drug was administered, patient experienced the following problems/side effects: maculopathy. MANNITOL dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE. Patient recovered.
Mannitol Side Effects Report #5414743-4
Physician from UNITED STATES reported MANNITOL problem on Aug 03, 2007. Female patient, 34 years of age, was diagnosed with blood brain barrier defect, lymphoma and was treated with MANNITOL. After drug was administered, patient experienced the following problems/side effects: maculopathy. MANNITOL dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE. Patient recovered.
Mannitol Side Effects Report #5414753-7
MANNITOL problem was reported by a Physician from UNITED STATES on Aug 03, 2007. Female patient, 54 years of age, was diagnosed with central nervous system lymphoma and was treated with MANNITOL. After drug was administered, patient experienced the following problems/side effects: maculopathy. MANNITOL dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE. Patient recovered.
Mannitol Side Effects Report #5414754-9
Physician from UNITED STATES reported MANNITOL problem on Aug 03, 2007. Female patient, 57 years of age, was diagnosed with blood brain barrier defect, central nervous system lymphoma and was treated with MANNITOL. After drug was administered, patient experienced the following problems/side effects: blood brain barrier defect, central nervous system lymphoma, maculopathy. MANNITOL dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE. Patient recovered.
Mannitol Side Effects Report #5414755-0
MANNITOL problem was reported by a Physician from UNITED STATES on Aug 03, 2007. Female patient, 65 years of age, was diagnosed with blood brain barrier defect, lymphoma and was treated with MANNITOL. After drug was administered, patient experienced the following problems/side effects: maculopathy, visual disturbance. MANNITOL dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE. Patient recovered.
Mannitol Side Effects Report #5414756-2
Physician from UNITED STATES reported MANNITOL problem on Aug 03, 2007. Female patient, 66 years of age, was diagnosed with blood brain barrier defect, central nervous system lymphoma and was treated with MANNITOL. After drug was administered, patient experienced the following problems/side effects: maculopathy. MANNITOL dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE. Patient recovered.
Mannitol Side Effects Report #5414757-4
MANNITOL problem was reported by a Physician from UNITED STATES on Aug 03, 2007. Female patient, 66 years of age, was diagnosed with blood brain barrier defect, lymphoma and was treated with MANNITOL. After drug was administered, patient experienced the following problems/side effects: maculopathy. MANNITOL dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, ETOPOSIDE PHOSPHATE, CYTARABINE. Patient recovered.